Johan Lindström

Johan Lindström has extensive work experience in the pharmaceutical industry. Johan started their career in 2005 at AstraZeneca as a Research Scientist, focusing on CNS therapeutic areas, specifically neuropathic pain and Alzheimer's disease. Johan then progressed to the role of Senior Research Scientist, where they led a team of chemists and managed external collaborations with CROs. In 2012, Johan joined Sprint Bioscience as an Associate Principal Scientist, responsible for medicinal chemistry. Johan later became the Principal Scientist for synthesis and, currently, they hold the position of Director of Medicinal Chemistry.

Johan Lindström obtained their M.Sc. degree in Organic Chemistry from The Faculty of Engineering at Lund University, where they studied from 2000 to 2005.